Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
91
-
Total 13F shares, excl. options
-
36.3M
-
Shares change
-
+2.54M
-
Total reported value, excl. options
-
$593M
-
Value change
-
+$40M
-
Put/Call ratio
-
7.37
-
Number of buys
-
47
-
Number of sells
-
-34
-
Price
-
$16.33
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q2 2019
116 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q2 2019.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.3M shares
of 49.8M outstanding shares and own 72.93% of the company stock.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (9.31M shares), FMR LLC (8.28M shares), VANGUARD GROUP INC (3.93M shares), BlackRock Inc. (3.83M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.14M shares), STATE STREET CORP (939K shares), NORGES BANK (928K shares), GEODE CAPITAL MANAGEMENT, LLC (586K shares), MORGAN STANLEY (559K shares), and NORTHERN TRUST CORP (554K shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.